Dr. Spirtos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 Shadow Ln
Ste 370
Las Vegas, NV 89106Phone+1 702-693-6870Fax+1 702-693-6899
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Gynecologic Oncology, 1985 - 1987
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Obstetrics and Gynecology, 1981 - 1984
- Northwestern University The Feinberg School of MedicineClass of 1980
Certifications & Licensure
- CA State Medical License 1981 - 2025
- NV State Medical License 1997 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Vegas Seven Castle Connolly, 2014
- America's Top Doctors Castle Connolly, 2006-2011, 2013-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Laparoscopic Approach to Cervical Cancer Start of enrollment: 2008 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over.Omali Pitiyarachchi, Peter J Ansell, Robert L Coleman, Minh H Dinh, Laura Holman
Gynecologic Oncology. 2024-08-01 - 2 citationsCorrigendum to "Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis" [Gynecologic Oncology ...Kimberly Levinson, Anna Beavis, Christopher Purdy, Anne F. Rositch, Akila N. Viswanathan
Gynecologic Oncology. 2021-10-12 - 31 citationsBeyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysisKimberly Levinson, Anna Beavis, Christopher Purdy, Anne F. Rositch, Akila N. Viswanathan
Gynecologic Oncology. 2021-09-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: